Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 21.53
-0.41 (-1.87%)
Oct 14, 2026, 11:29 AM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 4.28 billion as of October 13, 2026. It is the 13,116th most valuable company in the world and the 3,409th biggest in China. Its market cap has decreased by 45.50% in one year.
Market Cap
4.28B
Enterprise Value
5.13B
Revenue
1.44B
Global Rank
Country Rank
#3,409 China
PE Ratio
20.71
ChartMarket Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 4.28B, a decrease of -47.53%. That is a compound annual growth rate of -10.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 4.47B | -28.75% |
| Dec 31, 2025 | 6.27B | 45.13% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding